These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 2543220

  • 1. Treatment of invasive aspergillosis with itraconazole.
    Denning DW, Tucker RM, Hanson LH, Stevens DA.
    Am J Med; 1989 Jun; 86(6 Pt 2):791-800. PubMed ID: 2543220
    [Abstract] [Full Text] [Related]

  • 2. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis.
    Denning DW, Tucker RM, Hanson LH, Stevens DA.
    J Am Acad Dermatol; 1990 Sep; 23(3 Pt 2):602-7. PubMed ID: 2170480
    [Abstract] [Full Text] [Related]

  • 3. Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
    Schmitt HJ, Edwards F, Andrade J, Niki Y, Armstrong D.
    Chemotherapy; 1992 Sep; 38(2):118-26. PubMed ID: 1317280
    [Abstract] [Full Text] [Related]

  • 4. Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
    Moore L, Ellis DH, Suppiah R, Byard RW, Toogood IR.
    J Paediatr Child Health; 1993 Apr; 29(2):141-3. PubMed ID: 8387801
    [Abstract] [Full Text] [Related]

  • 5. Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
    Le Conte P, Joly V, Saint-Julien L, Gillardin JM, Carbon C, Yeni P.
    Am Rev Respir Dis; 1992 Feb; 145(2 Pt 1):424-9. PubMed ID: 1310577
    [Abstract] [Full Text] [Related]

  • 6. Successful treatment of Aspergillus flavus onychomycosis with oral itraconazole.
    Scher RK, Barnett JM.
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):749-50. PubMed ID: 2172334
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Early experience with itraconazole in vitro and in patients: pharmacokinetic studies and clinical results.
    Dupont B, Drouhet E.
    Rev Infect Dis; 1987 Oct; 9 Suppl 1():S71-6. PubMed ID: 3027850
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Oakley KL, Morrissey G, Denning DW.
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
    [Abstract] [Full Text] [Related]

  • 10. Experience with itraconazole in cryptococcosis and aspergillosis.
    Viviani MA, Tortorano AM, Langer M, Almaviva M, Negri C, Cristina S, Scoccia S, De Maria R, Fiocchi R, Ferrazzi P.
    J Infect; 1989 Mar; 18(2):151-65. PubMed ID: 2540243
    [Abstract] [Full Text] [Related]

  • 11. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
    Lortholary O, Meyohas MC, Dupont B, Cadranel J, Salmon-Ceron D, Peyramond D, Simonin D.
    Am J Med; 1993 Aug; 95(2):177-87. PubMed ID: 8395142
    [Abstract] [Full Text] [Related]

  • 12. Seventeen years of subcutaneous infection by Aspergillus flavus; eumycetoma confirmed by immunohistochemistry.
    Ahmed SA, Abbas MA, Jouvion G, Al-Hatmi AM, de Hoog GS, Kolecka A, Mahgoub el S.
    Mycoses; 2015 Dec; 58(12):728-34. PubMed ID: 26497138
    [Abstract] [Full Text] [Related]

  • 13. [Pseudotumoral naso-sinusal aspergillosis stabilized by itraconazole].
    Gresenguet G, Belec L, Testat J, Lesbordes JL, Dupont B, Georges AJ.
    Med Trop (Mars); 1989 Dec; 49(1):73-5. PubMed ID: 2542719
    [Abstract] [Full Text] [Related]

  • 14. Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis.
    Kreisel W, Köchling G, von Schilling C, Azemar M, Kurzweil B, Dölken G, Lindemann A, Blum U, Windfuhr M, Müller J.
    Mycoses; 1991 Dec; 34(9-10):385-94. PubMed ID: 1668178
    [Abstract] [Full Text] [Related]

  • 15. Itraconazole--perspectives for the management of invasive aspergillosis.
    Groll AH.
    Mycoses; 2002 Dec; 45 Suppl 3():48-55. PubMed ID: 12690972
    [Abstract] [Full Text] [Related]

  • 16. Aspergillus-induced discitis. A role for itraconazole in therapy?
    McGregor A, McNicol D, Collignon P.
    Spine (Phila Pa 1976); 1992 Dec; 17(12):1512-4. PubMed ID: 1335170
    [No Abstract] [Full Text] [Related]

  • 17. Primary cutaneous aspergillosis: our experience in 10 years.
    Chakrabarti A, Gupta V, Biswas G, Kumar B, Sakhuja VK.
    J Infect; 1998 Jul; 37(1):24-7. PubMed ID: 9733373
    [Abstract] [Full Text] [Related]

  • 18. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
    Longman LP, Martin MV.
    J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
    [Abstract] [Full Text] [Related]

  • 19. Treatment of pulmonary aspergilloma with itraconazole.
    Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW.
    Thorax; 1991 Nov; 46(11):839-41. PubMed ID: 1663275
    [Abstract] [Full Text] [Related]

  • 20. Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients.
    Negri CE, Gonçalves SS, Sousa ACP, Bergamasco MD, Martino MDV, Queiroz-Telles F, Aquino VR, Castro PTO, Hagen F, Meis JF, Colombo AL.
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28893772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.